Floxacillin
Showing 1 - 17 of 17
Cellulitis of Leg Trial (Flucloxacillin Only Product in Oral Dose Form, Placebo Only Product in Oral Dose Form)
Not yet recruiting
- Cellulitis of Leg
- Flucloxacillin Only Product in Oral Dose Form
- Placebo Only Product in Oral Dose Form
- (no location specified)
Oct 13, 2022
Bone Infection, Septic Arthritis, Bone and Joint Infection Trial in Australia, New Zealand (Oral cefalexin only, IV cefazolin or
Recruiting
- Bone Infection
- +3 more
- Oral cefalexin only
- IV cefazolin or IV flucloxacillin followed by oral cefalexin
-
Sydney, New South Wales, Australia
- +7 more
Jun 5, 2022
Cellulitis Trial in Parkville (Home, Ward, ceftriaxone)
Completed
- Cellulitis
- Home
- +3 more
-
Parkville, Victoria, AustraliaThe Royal Children's Hospital Melbourne
Nov 7, 2022
Healthy Volunteers, Drug Drug Interaction Trial in Odense (Flucloxacillin)
Completed
- Healthy Volunteers
- Drug Drug Interaction
-
Odense, Region Of Southern Denmark, DenmarkUniversity of Southern Denmark
Jan 10, 2022
Chronic Kidney Disease Trial in Leuven (Flucloxacillin)
Terminated
- Chronic Kidney Disease
-
Leuven, Vlaams-Brabant, BelgiumUniversitaire Ziekenhuizen Leuven
Apr 23, 2020
Staphylococcus Aureus Infection Trial in Worldwide (Trimethoprim-Sulfamethoxazole, Clindamycin, Linezolid)
Completed
- Staphylococcus Aureus Infection
- Trimethoprim-Sulfamethoxazole
- +7 more
-
Annecy, France
- +39 more
May 26, 2020
DetectAB - Detecting Antibiotics
Completed
- Antibiotic Drug Concentration in Sweat
- analysis of last resort antibiotic drug (Flucloxacillin, Imipenem, Vancomycin or Cefepim) in sweat and blood
-
Basel, SwitzerlandUniversity Hospital Basel
Dec 10, 2019
Flucloxacillin Given by Continuous or Intermittent Infusion to
Completed
- Bacterial Infections
-
Nijmegen, NetherlandsRadboud University Medical Center
Oct 22, 2018
Methicillin-Resistant Staphylococcus Aureus Trial in Worldwide (Beta-Lactam)
Terminated
- Methicillin-Resistant Staphylococcus Aureus
-
Blacktown, New South Wales, Australia
- +29 more
Dec 17, 2018
Infections, Bacterial Trial in Greifswald (flucloxacillin 250 mg, flucloxacillin 500 mg)
Completed
- Infections, Bacterial
- flucloxacillin 250 mg
- flucloxacillin 500 mg
-
Greifswald, Mecklenburg-Vorpommern, GermanyGSK Investigational Site
Sep 27, 2017
Staphylococcus Aureus Trial in Brisbane (Benzylpenicillin, Flucloxacillin)
Unknown status
- Staphylococcus Aureus
-
Brisbane, Queensland, AustraliaBrisbane Private Hospital
Aug 12, 2018
Cellulitis, Erysipelas Trial in Netherlands (Flucloxacillin, Placebo (for flucloxacillin))
Terminated
- Cellulitis
- Erysipelas
- Flucloxacillin
- Placebo (for flucloxacillin)
-
Almere, Flevoland, Netherlands
- +10 more
Oct 9, 2017
Valvular Heart Disease Trial in Changsha (ERAS group, Conventional control group)
Completed
- Valvular Heart Disease
- ERAS group
- Conventional control group
-
Changsha, Hunan, ChinaXiangya Hospital of Central South University
May 31, 2017
Cellulitis, Wound Infection, Abscess Trial in Blanchardstown, Cork, Dublin (Flucloxacillin, Phenoxymethylpenicillin, Placebo
Unknown status
- Cellulitis
- +2 more
- Flucloxacillin
- +2 more
-
Blanchardstown, Dublin, Ireland
- +4 more
Sep 30, 2016
Infections Trial in Worldwide (Daptomycin, Vancomycin or Semi-Synthetic Penicillins (SSPs))
Completed
- Infections
- Daptomycin
- Vancomycin or Semi-Synthetic Penicillins (SSPs)
-
Graz, Austria
- +16 more
Jul 9, 2012
Mastitis Trial in Helsingborg (Acupuncture treatment, Administration of oxytocin nasal spray, Improved breast milk removal)
Completed
- Mastitis
- Acupuncture treatment
- +8 more
-
Helsingborg, Skane, SwedenDept Obstetrics & Gynecology, Helsingborg Hospital
Nov 30, 2006